カテゴリー： QYResearch, 世界, 医療/バイオ

テノキシカムAPIのグローバル市場2023年：純度≧99%、純度≧99.5%

◆英語タイトル：Global Tenoxicam API Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8904）◆商品コード：QYR23MA8904
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：94
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のテノキシカムAPI市場について調査・分析し、世界のテノキシカムAPI市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（純度≧99%、純度≧99.5%）、用途別セグメント分析（経口、注射）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、TOKYO、INTATRADE、Service Chemical、LGM Pharma、Matrix、Senxuan Pharmaceutical、ShiShun Biotechnology、Dingxintong Pharmaceutical、J&K Scientific、Huibaishi Biotechnology、Meilun Biotechなどが含まれています。世界のテノキシカムAPI市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、テノキシカムAPI市場規模を推定する際に考慮しました。

・テノキシカムAPI市場の概要
- 製品の定義
- テノキシカムAPIのタイプ別セグメント
- 世界のテノキシカムAPI市場規模：タイプ別分析（純度≧99%、純度≧99.5%）
- テノキシカムAPIの用途別セグメント
- 世界のテノキシカムAPI市場規模：用途別分析（経口、注射）
- 世界のテノキシカムAPI市場規模予測（2018年-2029年）
- テノキシカムAPIの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- テノキシカムAPI市場の競争状況およびトレンド

・テノキシカムAPIの地域別市場規模
- 北米のテノキシカムAPI市場規模（2018年-2029年）
- アメリカのテノキシカムAPI市場規模（2018年-2029年）
- ヨーロッパのテノキシカムAPI市場規模（2018年-2029年）
- アジア太平洋のテノキシカムAPI市場規模（2018年-2029年）
- 中国のテノキシカムAPI市場規模（2018年-2029年）
- 日本のテノキシカムAPI市場規模（2018年-2029年）
- 韓国のテノキシカムAPI市場規模（2018年-2029年）
- インドのテノキシカムAPI市場規模（2018年-2029年）
- オーストラリアのテノキシカムAPI市場規模（2018年-2029年）
- 中南米のテノキシカムAPI市場規模（2018年-2029年）
- 中東・アフリカのテノキシカムAPI市場規模（2018年-2029年）

・タイプ別セグメント：純度≧99%、純度≧99.5%
- 世界のテノキシカムAPIのタイプ別販売量（2018年-2023年）
- 世界のテノキシカムAPIのタイプ別売上（2018年-2023年）
- 世界のテノキシカムAPIのタイプ別価格

・用途別セグメント：経口、注射
- 世界のテノキシカムAPIの用途別販売量（2018年-2023年）
- 世界のテノキシカムAPIの用途別売上（2018年-2023年）
- 世界のテノキシカムAPIの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
TOKYO、INTATRADE、Service Chemical、LGM Pharma、Matrix、Senxuan Pharmaceutical、ShiShun Biotechnology、Dingxintong Pharmaceutical、J&K Scientific、Huibaishi Biotechnology、Meilun Biotech

・産業チェーンと販売チャネルの分析
- テノキシカムAPI産業チェーン分析
- テノキシカムAPIの主要原材料
- テノキシカムAPIの販売チャネル
- テノキシカムAPIのディストリビューター
- テノキシカムAPIの主要顧客

・テノキシカムAPI市場ダイナミクス
- テノキシカムAPIの業界動向
- テノキシカムAPI市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Tenoxicam API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Tenoxicam API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Tenoxicam API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Tenoxicam API include TOKYO, INTATRADE, Service Chemical, LGM Pharma, Matrix, Senxuan Pharmaceutical, ShiShun Biotechnology, Dingxintong Pharmaceutical and J&K Scientific, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tenoxicam API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenoxicam API.
The Tenoxicam API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tenoxicam API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tenoxicam API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
TOKYO
INTATRADE
Service Chemical
LGM Pharma
Matrix
Senxuan Pharmaceutical
ShiShun Biotechnology
Dingxintong Pharmaceutical
J&K Scientific
Huibaishi Biotechnology
Meilun Biotech
Segment by Type
Purity≥ 99%
Purity≥ 99.5%
Segment by Application
Oral Doses
Injection
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tenoxicam API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tenoxicam API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Tenoxicam API Market Overview
1.1 Product Overview and Scope of Tenoxicam API
1.2 Tenoxicam API Segment by Type
1.2.1 Global Tenoxicam API Market Value Comparison by Type (2023-2029)
1.2.2 Purity≥ 99%
1.2.3 Purity≥ 99.5%
1.3 Tenoxicam API Segment by Application
1.3.1 Global Tenoxicam API Market Value by Application: (2023-2029)
1.3.2 Oral Doses
1.3.3 Injection
1.4 Global Tenoxicam API Market Size Estimates and Forecasts
1.4.1 Global Tenoxicam API Revenue 2018-2029
1.4.2 Global Tenoxicam API Sales 2018-2029
1.4.3 Global Tenoxicam API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tenoxicam API Market Competition by Manufacturers
2.1 Global Tenoxicam API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tenoxicam API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tenoxicam API Average Price by Manufacturers (2018-2023)
2.4 Global Tenoxicam API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tenoxicam API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tenoxicam API, Product Type & Application
2.7 Tenoxicam API Market Competitive Situation and Trends
2.7.1 Tenoxicam API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tenoxicam API Players Market Share by Revenue
2.7.3 Global Tenoxicam API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tenoxicam API Retrospective Market Scenario by Region
3.1 Global Tenoxicam API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tenoxicam API Global Tenoxicam API Sales by Region: 2018-2029
3.2.1 Global Tenoxicam API Sales by Region: 2018-2023
3.2.2 Global Tenoxicam API Sales by Region: 2024-2029
3.3 Global Tenoxicam API Global Tenoxicam API Revenue by Region: 2018-2029
3.3.1 Global Tenoxicam API Revenue by Region: 2018-2023
3.3.2 Global Tenoxicam API Revenue by Region: 2024-2029
3.4 North America Tenoxicam API Market Facts & Figures by Country
3.4.1 North America Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tenoxicam API Sales by Country (2018-2029)
3.4.3 North America Tenoxicam API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tenoxicam API Market Facts & Figures by Country
3.5.1 Europe Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tenoxicam API Sales by Country (2018-2029)
3.5.3 Europe Tenoxicam API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tenoxicam API Market Facts & Figures by Country
3.6.1 Asia Pacific Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tenoxicam API Sales by Country (2018-2029)
3.6.3 Asia Pacific Tenoxicam API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tenoxicam API Market Facts & Figures by Country
3.7.1 Latin America Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tenoxicam API Sales by Country (2018-2029)
3.7.3 Latin America Tenoxicam API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tenoxicam API Market Facts & Figures by Country
3.8.1 Middle East and Africa Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tenoxicam API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tenoxicam API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tenoxicam API Sales by Type (2018-2029)
4.1.1 Global Tenoxicam API Sales by Type (2018-2023)
4.1.2 Global Tenoxicam API Sales by Type (2024-2029)
4.1.3 Global Tenoxicam API Sales Market Share by Type (2018-2029)
4.2 Global Tenoxicam API Revenue by Type (2018-2029)
4.2.1 Global Tenoxicam API Revenue by Type (2018-2023)
4.2.2 Global Tenoxicam API Revenue by Type (2024-2029)
4.2.3 Global Tenoxicam API Revenue Market Share by Type (2018-2029)
4.3 Global Tenoxicam API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tenoxicam API Sales by Application (2018-2029)
5.1.1 Global Tenoxicam API Sales by Application (2018-2023)
5.1.2 Global Tenoxicam API Sales by Application (2024-2029)
5.1.3 Global Tenoxicam API Sales Market Share by Application (2018-2029)
5.2 Global Tenoxicam API Revenue by Application (2018-2029)
5.2.1 Global Tenoxicam API Revenue by Application (2018-2023)
5.2.2 Global Tenoxicam API Revenue by Application (2024-2029)
5.2.3 Global Tenoxicam API Revenue Market Share by Application (2018-2029)
5.3 Global Tenoxicam API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 TOKYO
6.1.1 TOKYO Corporation Information
6.1.2 TOKYO Description and Business Overview
6.1.3 TOKYO Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 TOKYO Tenoxicam API Product Portfolio
6.1.5 TOKYO Recent Developments/Updates
6.2 INTATRADE
6.2.1 INTATRADE Corporation Information
6.2.2 INTATRADE Description and Business Overview
6.2.3 INTATRADE Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 INTATRADE Tenoxicam API Product Portfolio
6.2.5 INTATRADE Recent Developments/Updates
6.3 Service Chemical
6.3.1 Service Chemical Corporation Information
6.3.2 Service Chemical Description and Business Overview
6.3.3 Service Chemical Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Service Chemical Tenoxicam API Product Portfolio
6.3.5 Service Chemical Recent Developments/Updates
6.4 LGM Pharma
6.4.1 LGM Pharma Corporation Information
6.4.2 LGM Pharma Description and Business Overview
6.4.3 LGM Pharma Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LGM Pharma Tenoxicam API Product Portfolio
6.4.5 LGM Pharma Recent Developments/Updates
6.5 Matrix
6.5.1 Matrix Corporation Information
6.5.2 Matrix Description and Business Overview
6.5.3 Matrix Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Matrix Tenoxicam API Product Portfolio
6.5.5 Matrix Recent Developments/Updates
6.6 Senxuan Pharmaceutical
6.6.1 Senxuan Pharmaceutical Corporation Information
6.6.2 Senxuan Pharmaceutical Description and Business Overview
6.6.3 Senxuan Pharmaceutical Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Senxuan Pharmaceutical Tenoxicam API Product Portfolio
6.6.5 Senxuan Pharmaceutical Recent Developments/Updates
6.7 ShiShun Biotechnology
6.6.1 ShiShun Biotechnology Corporation Information
6.6.2 ShiShun Biotechnology Description and Business Overview
6.6.3 ShiShun Biotechnology Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ShiShun Biotechnology Tenoxicam API Product Portfolio
6.7.5 ShiShun Biotechnology Recent Developments/Updates
6.8 Dingxintong Pharmaceutical
6.8.1 Dingxintong Pharmaceutical Corporation Information
6.8.2 Dingxintong Pharmaceutical Description and Business Overview
6.8.3 Dingxintong Pharmaceutical Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dingxintong Pharmaceutical Tenoxicam API Product Portfolio
6.8.5 Dingxintong Pharmaceutical Recent Developments/Updates
6.9 J&K Scientific
6.9.1 J&K Scientific Corporation Information
6.9.2 J&K Scientific Description and Business Overview
6.9.3 J&K Scientific Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 J&K Scientific Tenoxicam API Product Portfolio
6.9.5 J&K Scientific Recent Developments/Updates
6.10 Huibaishi Biotechnology
6.10.1 Huibaishi Biotechnology Corporation Information
6.10.2 Huibaishi Biotechnology Description and Business Overview
6.10.3 Huibaishi Biotechnology Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Huibaishi Biotechnology Tenoxicam API Product Portfolio
6.10.5 Huibaishi Biotechnology Recent Developments/Updates
6.11 Meilun Biotech
6.11.1 Meilun Biotech Corporation Information
6.11.2 Meilun Biotech Tenoxicam API Description and Business Overview
6.11.3 Meilun Biotech Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Meilun Biotech Tenoxicam API Product Portfolio
6.11.5 Meilun Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tenoxicam API Industry Chain Analysis
7.2 Tenoxicam API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tenoxicam API Production Mode & Process
7.4 Tenoxicam API Sales and Marketing
7.4.1 Tenoxicam API Sales Channels
7.4.2 Tenoxicam API Distributors
7.5 Tenoxicam API Customers
8 Tenoxicam API Market Dynamics
8.1 Tenoxicam API Industry Trends
8.2 Tenoxicam API Market Drivers
8.3 Tenoxicam API Market Challenges
8.4 Tenoxicam API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ テノキシカムAPIのグローバル市場2023年：純度≧99%、純度≧99.5%(Global Tenoxicam API Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 医療美容材料のグローバル市場2023年：ヒアルロン酸、コラーゲン、水素カルシウム、その他皮膚フィラー、ボツリヌストキシン、乳房インプラント、その他
  • 細胞療法用細胞凍結培地のグローバル市場2023年：血清含有凍結培地、無血清凍結培地
  • クレアチンキナーゼアッセイキットのグローバル市場2023年：酵素結合法、比色法
  • シトクロムCのグローバル市場2023年：液体、粉体
  • 顔＆唇用フィラーのグローバル市場2023年：ヒアルロン酸、コラーゲン、CaHA、その他